We found that in nonobese asthmatics, a history of ≥10 p/y smoking was associated with a higher TEC; but this did not reach statistical significance (Table 2 a).
← all excerpts
The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab-mepolizumab treatment efficiency in these patients.
1
—
—